Hypnotherapy for Crohn's disease: A promising complementary/alternative therapy

Integrative Medicine

Volumn 2, Issue 2-3, 2000, Pages 127-131

  Abela, Marcelle Bartolo ^a  

^a American Institute of Hypnotherapy   (United States)

Author keywords

Crohn's disease; Hypnotherapy; Immunology

Indexed keywords

ALTERNATIVE MEDICINE; CROHN DISEASE; HUMAN; HYPNOSIS; IMMUNOLOGY; IMMUNOMODULATION; REVIEW;

EID: 0033512672     PISSN: 10962190     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-2190(00)00005-6     Document Type: Review

References (59)

1. Inflammatory bowel disease guidelines. 1998;Clinical Services and Standards Committee, London.
2. Crohn's disease. 1999;National Institutes of Health, Bethesda, MD.
3. Stites D.P., Terr A.I., Parslow T.G. Basic and clinical immunology. 8th ed:1994;Prentice-Hall, London.
4. Beers M.H., Berkow R. The Merck manual of diagnosis and therapy. 17th ed:1999;Merck, Sharp, and Dohme, Whitehouse Station, NJ.
5. Ehrhardt R.O. New insights into the immunopathology of chronic inflammatory bowel disease. Semin Gastrointest Dis. 7:1996;144-150.
6. Schafer D.W. Hypnosis and the treatment of ulcerative colitis and Crohn's disease. Am J Clin Hypn. 40:1997;111-117.
7. Lashner B.A. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 24:1995;467-474.
8. von Wietersheim J., Kohler T., Feiereis H. Relapse-precipitating life events and feelings in patients with inflammatory bowel disease. Psychother Psychosom. 58:1992;103-112.
9. Duffy L.C., Zielezny M.A., Marshall J.R.et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med. 17:1991;101-110.
10. Paar G.H., Bezzenberger U., Lorenz-Meyer H. The correlation of psychosocial stress and disease activity in patients with Crohn disease and ulcerative colitis. Z Gastroenterol. 26:1988;648-657.
11. Anton P.A. Stress and mind-body impact on the course of inflammatory bowel diseases. Semin Gastrointest Dis. 10:1999;14-19.
12. Anton P.A., Shanahan F. Neuroimmunomodulation in inflammatory bowel disease. How far from "bench" to "bedside"? Ann NY Acad Sci. 840:1998;723-734.
13. Greene B.R., Blanchard E.B., Wan C.K. Long-term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease. Behav Res Ther. 32:1994;217-226.
14. Benton T.A. Curriculum for certification as a hypnotherapist. 1999;Winchester Hospital, The Community Health Institute, Woburn, MA.
15. Searleman A., Fugagli A.K. Suspected autoimmune disorders and left-handedness. Evidence from individuals with diabetes, Crohn's disease and ulcerative colitis Neuropsychologia. 25:1987;367-374.
16. Locke S, Kraus L, Leserman J, Hurst M, Hiesel S, Williams R. Life change stress, psychiatric symptoms, and natural killer-cell activity. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 225.
17. Maclean D, Reichlin S. Neuroendocrinology and the immune response, 1981. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 225.
18. Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993.
19. Rossi E.L., Cheek D.B. Mind-body therapy. Methods of ideodynamic healing in hypnosis. 1988;W.W. Norton, New York.
20. Smith R. The immune system is a key factor in the etiology of psychosocial disease, 1991. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 225.
21. Ader R. Behaviorally conditioned modulation of immunity, 1985. Abela M.B. Curative hypnotherapy is the stress remover of choice, to increase immunocompetence in patients with unremitting non-small cell lung cancer stages II, IIIA and IIIB. 1999;Protocol submitted to the National Institutes of Health, Office of Alternative Medicine, Bethesda, MD.
22. Ader R., Felter D., Cohen N. Psychoneuroimmunology, 1991. Abela M.B. Curative hypnotherapy is the stress remover of choice, to increase immunocompetence in patients with unremitting non-small cell lung cancer stages II, IIIA and IIIB. 1999;Protocol submitted to the National Institutes of Health, Office of Alternative Medicine, Bethesda, MD.
23. Gorczynski R., Macrae S., Kennedy M. Conditioned immune response associated with allogenic skin grafts in mice, 1982. Abela M.B. Curative hypnotherapy is the stress remover of choice, to increase immunocompetence in patients with unremitting non-small cell lung cancer stages II, IIIA and IIIB. 1999;Protocol submitted to the National Institutes of Health, Office of Alternative Medicine, Bethesda, MD.
24. Zachariae R., Bjerring P., Zachariae C.et al. Monocyte chemotactic activity in sera after hypnotically induced emotional states. Scand J Immunol. 34:1991;71-79.
25. Cacioppo J.T., Malarkey W.B., Kiecolt-Glaser J.K.et al. Heterogeneity in neuroendocrine and immune responses to brief psychosocial stressors as a function of autonomic cardiac activation. Psychosom Med. 57:1995;154-164.
26. Cacioppo J.T., Berntson G.G., Malarkey W.B.et al. Autonomic, neuroendocrine, and immune responses to psychological stress. The reactivity hypothesis Ann NY Acad Sci. 840:1998;664-673.
27. Kiecolt-Glaser J.K., Glaser R., Cacioppo J.T., Malarkey W.B. Marital stress. Immunologic, neuroendocrine, and autonomic correlates Ann NY Acad Sci. 840:1998;656-663.
28. Andersen B.L., Farrar W.B., Golden-Kreutz D.et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst. 90:1998;30-36.
29. Kiecolt-Glaser J.K., Glaser R. Psychoneuroimmunology. Can psychological interventions modulate immunity? J Consult Clin Psychol. 60:1992;569-575.
30. Whitehouse W.G., Dinges D.F., Orne E.C.et al. Psychosocial and immune effects of self-hypnosis training for stress management throughout the first semester of medical school. Psychosom Med. 58:1996;249-263.
31. Glaser R, Kennedy S, Lafuse W, et al. Psychological stress-induced modulation of interleukin 2 receptor gene expression and interleukin 2 production in peripheral blood leukocytes, 1990. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 225.
32. Padgett D.A., Sheridan J.F., Dorne J., Berntson G.G., Candelora J., Glaser R. Social stress and the reactivation of latent herpes simplex virus type I, 1998. Abela M.B. Curative hypnotherapy is the stress remover of choice, to increase immunocompetence in patients with unremitting non-small cell lung cancer stages II, IIIA and IIIB. 1999;Protocol submitted to the National Institutes of Health, Office of Alternative Medicine, Bethesda, MD.
33. Roszman T, Cross R, Brooks W, Markesbery W. Neuroimmunomodulation: Effects of neural lesions on cellular immunity, 1985. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 224-5.
34. Stein M, Schleifer S, Keller S. Hypothalamic influences on immune responses, 1981. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 224-5.
35. Besedovsky H, del Rey A, Sorkin E. Immunological-neuroendocrine feedback circuits, 1985. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 224-5.
36. Hall HR, Goldstein A. Neurotransmitters and host defense, 1985. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 224-5.
37. Esterling B.A., Kiecolt-Glaser J.K., Bodnar J.C., Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults, 1994. Abela M.B. Curative hypnotherapy is the stress remover of choice, to increase immunocompetence in patients with unremitting non-small cell lung cancer stages II, IIIA and IIIB. 1999;Protocol submitted to the National Institutes of Health, Office of Alternative Medicine, Bethesda, MD.
38. Malarkey W.B., Pearl D.K., Demeres L.M., Kiecolt-Glaser J.K., Glaser R. Influence of academic stress and season on 24-hour mean concentrations of ACTH, cortical, and beta-endorphin, 1995. Abela M.B. Curative hypnotherapy is the stress remover of choice, to increase immunocompetence in patients with unremitting non-small cell lung cancer stages II, IIIA and IIIB. 1999;Protocol submitted to the National Institutes of Health, Office of Alternative Medicine, Bethesda, MD.
39. 39. Crawford HJ. Brain dynamics and hypnosis: Attentional and disattentional processes, 1994. Cited in: Abela MB. The physiology of hypnosis with implications for therapy. Nashua, NH: Paper submitted to the National Guild of Hypnotists, Board Certification Examination Committee; 1999.
40. Abela M.B. The physiology of hypnosis with implications for therapy. 1999;Paper submitted to the National Guild of Hypnotists, Board Certification Examination Committee, Nashua, NH.
41. Sgoutas-Emch S.A., Cacioppo J.T., Uchino B.N.et al. The effects of an acute psychological stressor on cardiovascular, endocrine, and cellular immune response. A prospective study of individuals high and low in heart rate activity Psychophysiology. 31:1994;264-271.
42. Ader R. Psychoneuroimmunology. 1981;Academic Press, New York.
43. Ader R. Behavioral conditioning and the immune system, 1983. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 217.
44. Ghanta V., Hiramoto R., Solvason H., Spector N. Neural and environmental influences on neoplasia and conditioning of NK activity. J Immun. 135:1985;848s-852s.
45. Solomon G. The emerging field of psychoneuroimmunology with a special note on AIDS. Advances. 2(Winter):1985;6-19.
46. Abela M.B. An attempt to define hypnosis, hypnotherapy, and curative hypnotherapy according to current evidence. 1998;Paper presented to the Association of Qualified Curative Hypnotherapists, The Committee, Birmingham, UK.
47. Levitan A.A. The use of hypnosis with cancer patients, 1992. Abela M.B. Curative hypnotherapy is the stress remover of choice, to increase immunocompetence in patients with unremitting non-small cell lung cancer stages II, IIIA and IIIB. 1999;Protocol submitted to the National Institutes of Health, Office of Alternative Medicine, Bethesda, MD.
48. Simonton C.O., Matthews-Simonton S., Creighton J.L. Getting well again. 1978;Bantam Books, New York.
49. Hall H.R., Mumma G.H., Longo S., Dixon R. Voluntary immunomodulation. A preliminary study Int J Neurosci. 63:1992;275-285.
50. Hall H.R., Minnes L., Tosi M., Olness K. Voluntary modulation of neutrophil adhesiveness using a cyberphysiologic strategy. Int J Neurosci. 63:1992;287-297.
51. Schneider J, Smith W, Witcher S. The relationship of mental imagery to white blood cell (neutrophil) function: Experimental studies of normal subjects, 1983. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 226-7.
52. Schneider J, Smith W, Witcher S. The relationship of mental imagery to white blood cell (neutrophil) function in normal subjects, 1984. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 226-7.
53. Sachar E.J., Fishman J.R., Mason J.W. Influence of the hypnotic trance on plasma 17-hydroxycorticosteroid concentration. Psychosom Med. 27:1965;330-341.
54. Hall HR. Hypnosis and the immune system: A review with implications for cancer and the psychology of healing. Am J Clin Hypn 1982-3;25:92-103.
55. Ruzyla-Smith P., Barabasz A., Barabasz M., Warner D. Effects of hypnosis on the immune response. B-cells, T-cells, helper and suppressor cells Am J Clin Hypn. 38:1995;71-79.
56. Zachariae R., Hansen J.B., Andersen M.et al. Changes in cellular immune function after immune specific guided imagery and relaxation in high and low hypnotizable healthy subjects. Psychother Psychosom. 61:1994;74-92.
57. Black S, Humphrey JH, Niven JSF. Inhibition of Mantoux reaction by direct suggestion under hypnosis, 1963. Cited in: Crasilneck HB, Hall JA. Clinical hypnosis: Principles and applications. 2nd ed. Boston, MA: Allyn and Bacon; 1985. p. 370.
58. Smith G, McDaniel S. Psychologically mediated effect on the delayed hypersensitivity reaction to tuberculin in humans, 1983. Cited in: Rossi EL. The psychobiology of mind-body healing. New concepts of therapeutic hypnosis. Revised edition. New York: W.W. Norton; 1993. p. 237-8.
59. Black S. Shift in dose-response curve of Prausnitz-Kuestner reaction by direct suggestion under hypnosis, 1963. Cited in: Crasilneck HB, Hall JA. Clinical hypnosis: Principles and applications. 2nd ed. Boston, MA: Allyn and Bacon; 1985. p. 370.